Research Funding

4D Nucleome

Title NIH Guide RFA Number Common Fund Contact Estimated
Receipt Date

Real Time Chromatin Dynamics and Function (U01 Clinical Trial Not Allowed)

11/25/2019 RFA-RM-20-003 Olivier Blondel
blondelol@niddk.nih.gov
 301-451-7334
Letter of Intent:
2/17/2020
Receipt Date:
3/17/2020
4DN Centers for Data Integration, Modeling and Visualization (UM1 Clinical Trial Not Allowed) 11/25/2019 RFA-RM-20-004 Mike Pazin
michael.pazin@nih.gov
301-496-7531
Letter of Intent:
2/17/2020
Receipt Date:
3/17/2020
4DN Organization and Function in Human Health and Disease (U01 Clinical Trial Not Allowed) 11/25/2019 RFA-RM-20-005 John Satterlee
rleej@nida.nih.gov
301-435-1020
Letter of Intent:
30 days prior to the
application
due date
Receipt Date:
3/2/2020
New Investigator Projects on 4DN Organization and Function in Human Health and Disease (U01 Clinical Trial Not Allowed) 11/25/2019 RFA-RM-20-006 Lisa Postow
lisa.postow@nih.gov
301-435-0202
Letter of Intent:
30 days prior to the
application
due date
Receipt Date:
3/2/2020
Limited Competition: 4DN Organizational Hub (U01 Clinical Trial Not Allowed) 12/20/2019 RFA-RM-20-007 Ian Fingerman
ian.fingerman@nih.gov
240-276-6250
Letter of Intent:
2/17/2020
Receipt Date:
3/17/2020
Limited Competition 4DN Data Coordination & Integration Center (U01 Clinical Trial Not Allowed) 12/20/2019 RFA-RM-20-008 Sean E. Hanlon
sean.hanlon@nih.gov
240-781-3310
Letter of Intent:
2/17/2020
Receipt Date:
3/17/2020

Acute to Chronic Pain Signatures

Title NIH Guide RFA Number Common Fund Contact Estimated
Receipt Date

Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Peri-operative Pain or Musculoskeletal Trauma (UM1 Clinical Trial Optional)

8/29/2019 RFA-RM-19-013 Linda L. Porter
porterl@ninds.nih.gov
301-435-7572
Letter of Intent:
10/25/2019
Receipt Date:
12/27/2019

Diversity Program Consortium: Enhancing the Diversity of the NIH-Funded Workforce

Title NIH Guide RFA Number Common Fund Contact Applications Receipt Date
Sponsored Programs Administration Development (SPAD) Program (UC2 - Clinical Trial Not Allowed) 5/17/2019 RFA-RM-19-004 Luis Cubano
luis.cubano@mail.nih.gov
301-594-3900
7/25/2019 and 
6/26/2020

Gabriella Miller Kids First

Title NIH Guide RFA Number Common Fund Contact Applications Receipt Date
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) 10/3/2019 PAR-19-390 Jonathan Kaltman
kaltmanj@mail.nih.gov
301-435-0510
James Coulombe
CoulombeJ@mail.nih.gov
301-451-1390
Adam Felsenfeld
adam_felsenfeld@nih.gov
301-496-7531
Malcolm A. Smith
Malcolm.Smith@nih.gov
240-276-6087
Jaime M. Guidry Auvil
jaime.guidryauvil@nih.gov
301-451-8027
Letter of Intent:
12/31/2019
Receipt Date:
1/31/2020

Glycoscience

Title NIH Guide RFA Number Common Fund Contact Applications Receipt Date
Notice of Special Interest (NOSI): Availability of Administrative Supplements to Accelerate Dissemination of Emerging Glycoscience Tools through Collaborations Between Developers and Early Adopters 12/19/2019 NOT-RM-20-003 Pamela Marino
MARINOP@nigms.nih.gov
First available due date:
2/11/2020
Expiration Date:
4/1/2020

High-Risk Research: NIH Director's Early Independence Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 8/22/2018 PA-18-906 Ravi Basavappa
earlyindependence@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
earlyindependence@mail.nih.gov
301 435-7204
 

High-Risk Research: NIH Director's New Innovator Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 8/22/2018 PA-18-906 Ravi Basavappa
NewInnovatorAward@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
NewInnovatorAward@mail.nih.gov
301 435-7204
 


High-Risk Research: NIH Director's Pioneer Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 8/22/2018 PA-18-906 Ravi Basavappa
PioneerAwards@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
PioneerAwards@mail.nih.gov
301 435-7204
 


High-Risk Research: NIH Director's Transformative Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 8/22/2018 PA-18-906 Ravi Basavappa
Transformative_Awards@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
Transformative_Awards@mail.nih.gov
(301) 435-7204
 

Human BioMolecular Atlas Program

Title NIH Guide RFA Number Common Fund Contact Estimated
Receipt Date

Transformative Technology Development for the Human BioMolecular Atlas Program (UG3/UH3 Clinical Trial Not Allowed)

12/2/2019 RFA-RM-20-001 Pothur Srinivas
HUBMAP@mail.nih.gov
301-402-3712
Letter of Intent:
02/02/2020
Receipt Date:
03/03/2020
Tissue Mapping Centers for the Human BioMolecular Atlas Program (U54 Clinical Trial Not Allowed) 12/2/2019 RFA-RM-20-002 Zorina Galis
HUBMAP@mail.nih.gov
301-435-0560
Letter of Intent:
02/02/2020
Receipt Date:
03/03/2020

Molecular Transducers of Physical Activity

Title NIH Guide RFA Number Common Fund Contact Estimated
Receipt Date

MoTrPAc Phase 2 Animal Studies (U01 Clinical Trial Not Allowed)

1/10/2020 RFA-RM-20-009 John P Williams
williamsj6@mail.nih.gov
301-496-6403
Letter of Intent:
02/20/2020
Receipt Date:
03/20/2020

This page last reviewed on January 10, 2020